Sanius Health Acquires THERAPYAUDIT to Expand AI Infrastructure Across 35+ NHS Hospitals

Why It Matters

The acquisition accelerates AI‑enabled care coordination across the NHS, delivering actionable insights that can improve patient outcomes and speed therapeutic research.

Key Takeaways

• Acquisition integrates therapy audit into Sanius AI platform
• Platform now spans 35+ NHS hospitals nationwide
• Enables real‑time monitoring of complex cancer treatments
• Generates real‑world evidence for regulators and pharma
• Boosts research collaboration across London‑Cambridge‑Oxford corridor

Pulse Analysis

The merger of Sanius Health and THERAPYAUDIT reflects a broader shift toward integrated digital ecosystems in British healthcare. By coupling THERAPYAUDIT’s therapy audit capabilities with Sanius’s AI‑powered analytics, hospitals can move beyond static record‑keeping to dynamic, predictive care pathways. This synergy not only streamlines multidisciplinary coordination for oncology, haematology and rare diseases but also creates a unified data lake that fuels longitudinal disease registries, a critical asset for clinicians seeking early warning signals and for researchers tracking treatment efficacy in real‑world settings.

Real‑world evidence has become a cornerstone for regulators and pharmaceutical companies as advanced therapies and precision medicines move from trials to routine practice. The expanded platform aggregates therapy delivery data across more than 35 NHS trusts, delivering granular insights into outcomes, safety profiles, and patient adherence. Such data depth enables faster regulatory feedback loops, informs pricing negotiations, and supports adaptive trial designs, ultimately reducing time‑to‑market for innovative treatments while safeguarding patient safety.

Strategically, the acquisition bolsters Sanius’s presence in the UK’s vibrant life‑science corridor, linking London’s fintech‑health talent pool with Cambridge’s biotech hub and Oxford’s research institutions. This geographic concentration fosters collaborative innovation, attracting investment in AI‑enabled care coordination and expanding the ecosystem of digital health partners. For the NHS, the combined platform promises scalable solutions to rising demand and increasingly complex therapeutic pathways, positioning the public health system at the forefront of data‑driven medicine.

Deal Summary

London-based AI and patient data platform Sanius Health has completed the acquisition of Cambridge digital health company THERAPYAUDIT for an undisclosed cash consideration. The deal expands Sanius's AI infrastructure to over 35 NHS hospitals, enhancing therapy monitoring and predictive analytics capabilities. The integration aims to improve care coordination and real-world evidence generation across complex disease pathways.